Best Practices for Assessing and Managing

Side Effects of CLL Therapies

Overview of Initial Treatment Options
Overview of Initial Treatment Options
Overview of Initial Treatment Options
Overview of Initial Treatment Options
Overview of Initial Treatment Options
Overview of Initial Treatment Options
Overview of Treatment Options for R/R CLL
Nursing Pearls to Prepare Patients to Start
an Oral CLL Therapy
Patient Education
Key Expectations
Starting Patients on Oral CLL Therapy
Role of the Clinical Pharmacist
Patient Scenario 1
Patient Scenario 1
Treatment Options
Venetoclax + Obinutuzumab
Preparing for Therapy and TLS Prophylaxis
Venetoclax + Obinutuzumab
Dietary Considerations
Venetoclax + Obinutuzumab
AEs of Interest
Venetoclax + Obinutuzumab
AEs of Interest
Venetoclax + Obinutuzumab
Expert Insights
Managing & Monitoring Venetoclax Ramp-
Up
Role of the Nurse
Managing Venetoclax Ramp-Up in the
Outpatient Setting
Nurses Play an Important Role in
Patient Education and Monitoring
Patient Scenario 2
Key Side Effects of BTK Inhibitors
Managing BTK Inhibitor-Associated Atrial
Fibrillation
Pharmacy Considerations for BTK Inhibitors
Patient Counseling Points
Pharmacy Considerations for BTK Inhibitors
Atrial Fibrillation and Bleeding
Side Effects of Phosphatidylinositol 3-Kinase (PI3K)
Inhibitors
Expert Considerations
Side Effects of Phosphatidylinositol 3-Kinase (PI3K)
Inhibitors
Expert Considerations (cont)
Monoclonal Antibodies in CLL
Minimizing and Managing Infusion Reactions
Strategies for Managing Infusion Reactions
Strategies for Managing Infusion Reactions
(cont)
Summary
Abbreviations